SCOTUS Passes on Petition to Reconsider Eligibility of Isolated Vitamin B3 Claims

The U.S. Supreme Court on Monday denied certiorari to review a February ruling of the U.S. Court of Appeals for the Federal Circuit (CAFC) that held claims of ChromaDex, Inc.’s patent on an isolated form of vitamin B3 are directed to unpatentable subject matter under Section 101.

Related Keywords

Delaware ,United States ,Sherry Knowles ,Alice Mayo ,Us District Court ,Us Supreme Court On ,Us Court ,Genetics Inc ,Elysium Health ,Association For Molecular Pathology ,Chromadex Inc ,Ipwatchdog Life Sciences Masters ,Supreme Court ,Federal Circuit ,Molecular Pathology ,Life Sciences Masters ,